Targeting Ubiquitin-Specific Protease 7 with Novel 5-Amino-Pyrazole Inhibitors: Design, Synthesis, and Biological
Matteo Lusardi1,2, Elva Morretta3, Andrea Spallarossa1
1Department of Pharmacy, Università degli Studi di Genova, viale Benedetto XV, 3, 16132, Genova, Italy.
Chemmedchem
|June 24, 2025
Summary
New 5-aminopyrazole derivatives were synthesized to inhibit ubiquitin-specific protease 7 (USP-7). Compound 1d demonstrated potent, dose-dependent USP-7 inhibition with favorable non-cytotoxicity and permeability properties.
Area of Science:
- Medicinal Chemistry
- Enzyme Inhibition
- Drug Discovery
Background:
- Ubiquitin-specific protease 7 (USP-7) is a key target in various diseases.
- Structure-activity relationships (SARs) of USP-7 inhibitors require further exploration.
- Previous lead compound STIRUR-41 provides a basis for developing novel inhibitors.
Purpose of the Study:
- To design and synthesize novel 5-aminopyrazole derivatives.
- To evaluate the inhibitory potential of these derivatives against USP-7.
- To extend the SARs of USP-7 inhibitors.
Main Methods:
- Synthesis of 5-aminopyrazole library (compounds 1a-d and 2a-d).
- Confirmation of chemical structures using NMR and X-ray crystallography.
- In vitro enzymatic assays to determine IC50 values.
- Cytotoxicity assays and permeability studies (PAMPA).
- Molecular docking and dynamics simulations.
Main Results:
- Compounds 1a-d exhibited dose-dependent inhibition of USP-7 with lower IC50 values than STIRUR-41.
- Compound 1d, featuring a meta-trifluoromethylphenyl group, was the most potent inhibitor.
- Compounds from series 2 showed no activity due to steric hindrance.
- Series 1 compounds were non-cytotoxic across various cell lines at 10 μM.
- Compound 1d displayed favorable permeability characteristics.
Conclusions:
- Novel 5-aminopyrazoles are effective USP-7 inhibitors.
- Compound 1d represents a promising lead candidate for further development.
- SAR insights indicate that steric hindrance negatively impacts USP-7 inhibition.
- The developed compounds show potential for therapeutic applications with good safety profiles.


